CAS 146464-95-1 appears in our catalog under these names: Pralatrexate, min. 95 %, 5 mg, Pralatrexate, min. 95 %, 10 mg, Pralatrexate, min. 95 %, 25 mg, Pralatrexate, min. 95 %, 50 mg, Pralatrexate, min. 95 %, 100 mg. Offered by: Roth, Fluorochem, Combi-blocks, Chemat Brand, AmBeed. Available pack sizes: 5mg, 10mg, 25mg, 50mg, 100mg, 1g, 250mg, on request.
Pralatrexate is a pteridine that is the N-4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl derivative of L-glutamic acid. Used for treatment of Peripheral T-Cell Lymphoma, an aggressive form of non-Hodgkins lymphoma. It has a role as an antimetabolite, an antineoplastic agent and an EC 1.5.1.3 (dihydrofolate reductase) inhibitor. It is a N-acyl-L-glutamic acid, a member of pteridines and a terminal acetylenic compound.
Source: ChEBI
| Molecular formula | C23H23N7O5 |
|---|---|
| Molecular weight | 477.5 g/mol |
| IUPAC name | (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid |
| InChIKey | OGSBUKJUDHAQEA-WMCAAGNKSA-N |
| SMILES | C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O |
Computed by PubChem (NCBI)